قالب وردپرس درنا توس
Home / Insurance / NSAIDs account for one third of all drugs distributed: CWCI

NSAIDs account for one third of all drugs distributed: CWCI



Non-steroidal anti-inflammatory drugs now account for more than one-third of all drugs distributed to injured workers, and only two NSAIDs account for two-thirds of the prescription amount in that drug category, according to a report released Wednesday by California Workers Compensation [19659002] Oakland, California-based CWCI analyzed changes in the distribution of work compositions and prescription payments in the state over the past decade and found that opioid prescriptions have dropped 62% since 2011, while NSAIDs rose to become no. A pharmaceutical group was prescribed in 2015 and continues to hold that position.

NSAIDs accounted for almost 24% of total drug expenditures in 2020, compared with 1

4% in 2018, when the state's drug form came into force.

While more than two-thirds of all NSAIDs were prescriptions for ibuprofen and naproxen, the sharp increase was due to payments for two expensive drugs – phenoprofen calcium and ketoprofen – used according to the report.

The average amount of a prescription for phenoprofen calcium was $ 1,479 in 2020 – an increase of 636% compared to the average fee in 2016, which corresponds to more than a quarter of NSAID drug expenditures in 2020, even though they represent only 1% of prescriptions. The average amount paid for ketoprofen in 2020 was $ 1,097, an increase of 10 times from $ 99 in 2016.

According to the terms of the state fee schedule, prescriptions for unlisted drugs are paid at 83% of the average wholesale price established by pharmaceutical manufacturers.

Opioids remained the second most prescribed drug category in 2020, but the drug's share of the prescription amount decreased from 30.7% in 2011 to 7% in 2020. It ranked the drug group fourth in terms of total drug spending behind NSAIDs (23.5%), dermatological drugs ( 14.1%) and anticonvulsants (13.1%).

Prescriptions for muscle relaxants, which had been the third most prescribed group of drugs for work compensation before the adoption of the form, decreased sharply between 2018 and 2020, as drugs in that category are subject to review of use. Catalog

Catalog


Source link